copy number analysis
Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East
Blueprint Genetics' 419-gene panel detects single nucleotide variants and analyzes noncoding variants associated with skeletal dysplasia.
Oncocyte to Acquire Chronix Biomedical
The move will add Chronix's proprietary technology for blood-based immune therapy monitoring and transplant rejection testing to Oncocyte's existing test menu.
Bionano Customers Explore Diagnostic Applications of Genome Maps in Cancer, Genetic Disorders
Premium
Several groups are comparing Bionano with standard cytogenetic assays like karyotyping, FISH, or array CGH for blood cancer or genetic disease testing.
The findings, published last week, have prompted Belgian medical genetics centers to routinely report maternal incidental findings from NIPT.